NDRG3 and hepatocellular carcinoma: Previous studies have demonstrated thatmiR-122inhibits hepatitis B virus (HBV) replication by targeting NDRG3 in hepatocellular carcinoma cells (HCC) or HCC-derived cell lines [59].